Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept vs verteporfin in ophthalmic disease (Japan, Phase 4)
jRCT1080222583Phase 4Completed
- Start
- Aug 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
01
Overview
Phase 4 trial of aflibercept in well-being (2 arms). Started Aug 2014; status: completed.
02
Drugs
aflibercept
03
Conditions
well-being
Beyond the preview
Go deeper on jRCT1080222583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222583.